FFS
MRNA icon

Founders Financial Securities’s Moderna MRNA Stock Holding History

Founders Financial Securities’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,143
Closed -$440K – 274
2021
Q3 		$440K Sell
1,143
-607
-35% -$224K 0.09% 182
2021
Q2 		$411K Buy
1,750
+177
+11% +$31.6K 0.08% 193
2021
Q1 		$206K Buy
+1,573
New +$228K 0.05% 246

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Founders Financial Securities's MRNA Position: Q4 2021 in Review

Founders Financial Securities sold out of Moderna (MRNA) in Q4 2021, closing a stake of 1,143 shares — an estimated $440K sold.

Founders Financial Securities first reported a position in MRNA in Q1 2021 and held it in 3 quarters. The position peaked at $440K in Q3 2021. 1,109 funds tracked by Wall St. Rank hold MRNA as of Q4 2021.

  • Founders Financial Securities reported no remaining Moderna position as of Q4 2021 after selling out during the quarter.
  • Founders Financial Securities sold 1,143 Moderna shares in Q4 2021, an estimated $440K.
  • Founders Financial Securities first reported a position in Moderna in Q1 2021 and held it in 3 quarters.
  • Founders Financial Securities's Moderna position peaked at $440K in Q3 2021.
  • 1,109 funds tracked by Wall St. Rank held Moderna as of Q4 2021.

Based on Founders Financial Securities's 13F filing for Q4 2021, filed 14 Feb 2022.